Rivaroxaban in Patients With Atrial Fibrillation Undergoing PCI

Clinical trial NCT03315650 · COMPLETED

Trial details

NCT number: NCT03315650
Sponsor: IHF GmbH - Institut für Herzinfarktforschung
Status: COMPLETED
Study type: OBSERVATIONAL

Non-valvular Atrial Fibrillation Acute Coronary Syndrome Percutaneous Coronary Intervention Antithrombotic Therapy

Start date: 2018-01-01
Primary completion: 2020-03-31
Enrollment: 1632

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.